BIOLASE (BIOL) Competitors $0.01 +0.00 (+13.21%) As of 06/30/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock BIOL vs. AVGR, NUWE, NAYA, DYNT, CUTR, SONX, STSS, HSDT, IONM, and AFIBShould you be buying BIOLASE stock or one of its competitors? The main competitors of BIOLASE include Avinger (AVGR), Nuwellis (NUWE), NAYA Biosciences (NAYA), Dynatronics (DYNT), Cutera (CUTR), Sonendo (SONX), Sharps Technology (STSS), Helius Medical Technologies (HSDT), Assure (IONM), and Acutus Medical (AFIB). These companies are all part of the "medical equipment" industry. BIOLASE vs. Its Competitors Avinger Nuwellis NAYA Biosciences Dynatronics Cutera Sonendo Sharps Technology Helius Medical Technologies Assure Acutus Medical Avinger (NASDAQ:AVGR) and BIOLASE (NASDAQ:BIOL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership. Is AVGR or BIOL more profitable? Avinger has a net margin of 0.00% compared to BIOLASE's net margin of -41.65%. Avinger's return on equity of 0.00% beat BIOLASE's return on equity.Company Net Margins Return on Equity Return on Assets AvingerN/A N/A N/A BIOLASE -41.65%-1,782.73%-55.31% Do analysts rate AVGR or BIOL? BIOLASE has a consensus price target of $1.20, indicating a potential upside of 9,900.00%. Given BIOLASE's stronger consensus rating and higher probable upside, analysts clearly believe BIOLASE is more favorable than Avinger.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avinger 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00BIOLASE 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, AVGR or BIOL? Avinger has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, BIOLASE has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500. Which has preferable valuation & earnings, AVGR or BIOL? Avinger has higher earnings, but lower revenue than BIOLASE. Avinger is trading at a lower price-to-earnings ratio than BIOLASE, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvinger$7.65M0.21-$18.32M-$11.06-0.04BIOLASE$48.83M0.01-$20.63M-$14.940.00 Does the media refer more to AVGR or BIOL? In the previous week, Avinger's average media sentiment score of 0.00 equaled BIOLASE'saverage media sentiment score. Company Overall Sentiment Avinger Neutral BIOLASE Neutral Do institutionals and insiders believe in AVGR or BIOL? 18.3% of Avinger shares are owned by institutional investors. Comparatively, 8.8% of BIOLASE shares are owned by institutional investors. 42.8% of Avinger shares are owned by insiders. Comparatively, 0.3% of BIOLASE shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryAvinger beats BIOLASE on 9 of the 14 factors compared between the two stocks. Get BIOLASE News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIOL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOL vs. The Competition Export to ExcelMetricBIOLASEDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$401K$447K$5.48B$8.94BDividend YieldN/AN/A5.38%4.12%P/E Ratio0.00N/A26.2119.74Price / Sales0.010.01395.44109.12Price / CashN/AN/A36.4957.06Price / Book-0.170.017.935.37Net Income-$20.63M-$40.78M$3.15B$248.34M7 Day PerformanceN/AN/A0.75%1.67%1 Month PerformanceN/A-12.21%3.45%4.56%1 Year PerformanceN/AN/A34.85%18.42% BIOLASE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOLBIOLASE0.9962 of 5 stars$0.01+13.2%$1.20+9,900.0%-88.9%$401K$48.83M0.00160Gap UpAVGRAvingerN/A$0.47flatN/AN/A$1.57M$7.65M-0.0470NUWENuwellis2.4212 of 5 stars$0.30+10.7%$17.00+5,647.1%-95.3%$1.17M$8.74M-0.0270News CoverageHigh Trading VolumeNAYANAYA BiosciencesN/A$1.22-3.2%$24.00+1,867.2%N/A$813K$6.23M0.0010DYNTDynatronicsN/A$0.08-11.4%N/A-62.8%$810K$33.60M-0.09200Gap DownCUTRCuteraN/A$0.04-63.9%$3.00+7,592.3%-97.4%$787K$155.21M-0.01460Gap DownHigh Trading VolumeSONXSonendoN/A$1.15flatN/AN/A$493K$44.40M-0.02250STSSSharps Technology0.3569 of 5 stars$5.35+2.9%N/AN/A$280KN/A0.003HSDTHelius Medical Technologies0.3295 of 5 stars$0.32-3.0%N/A-98.8%$170K$520K-0.0130Stock SplitGap DownHigh Trading VolumeIONMAssureN/A$0.05flatN/A-99.6%$150K$149K0.00130Upcoming EarningsAFIBAcutus MedicalN/A$0.00+13.8%N/A-93.8%$98K$7.16M0.00340News CoverageGap Up Related Companies and Tools Related Companies Avinger Alternatives Nuwellis Alternatives NAYA Biosciences Alternatives Dynatronics Alternatives Cutera Alternatives Sonendo Alternatives Sharps Technology Alternatives Helius Medical Technologies Alternatives Assure Alternatives Acutus Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIOL) was last updated on 7/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
